Align Tech Maintains Buy Rating at $275.00 Price Target

Stifel Nicolaus maintains a Buy rating for Align Tech with a price target of $275.00. The company's shares closed at $192.81. Block, a healthcare sector expert, has a 5.3% average return and a 49.71% success rate on recommended stocks. Align Tech's latest earnings report showed a quarterly revenue of $979.26 million and a net profit of $93.23 million. The analyst consensus rating is Moderate Buy with a $233.91 average price target, a 21.32% upside from current levels.

Align Technology (ALGN), a leading provider of clear aligner orthodontic solutions, has been receiving a mix of analyst ratings, with a majority favoring a buy recommendation. The company's shares closed at $192.81 on July 2, 2025, following a period of mixed analyst sentiment.

According to TipRanks, a financial research platform, 13 analysts have provided ratings for ALGN over the past three months, with 13 analysts rating it as a "Moderate Buy," 9 as a "Buy," 3 as a "Hold," and 1 as a "Sell." The average price target for ALGN is $233.91, representing a 21.32% upside from the current share price of $192.81 [1].

Stifel Nicolaus, a leading investment bank, maintains a "Buy" rating for ALGN with a price target of $275.00. The analyst, Jonathan Block, has a 5.3% average return and a 49.71% success rate on recommended stocks, making him one of the top-performing analysts in the healthcare sector [1].

Align Tech's latest earnings report showed a quarterly revenue of $979.26 million and a net profit of $93.23 million. The company's earnings per share (EPS) for the previous quarter was $2.13, and the consensus estimate for the next quarter is $2.57, with a range of $2.53 to $2.62 [1].

Despite the positive earnings report, some analysts have expressed caution. For instance, Bank of America Securities has a "Sell" rating for ALGN, citing market challenges and revised growth targets. The analyst expects the stock to decline by 2.16% [1].

The mixed analyst sentiment reflects the company's growth prospects. While ALGN has shown strong performance in certain segments, such as clear aligners, it faces challenges in other segments and foreign exchange impacts. Additionally, the stock's valuation, as indicated by its high P/E ratio and overbought signals, may warrant caution [1].

Investors should closely monitor Align Tech's earnings reports and analyst ratings to gauge the company's future prospects. The mixed analyst sentiment suggests that while the stock has upside potential, it also carries risks that investors should consider.

References:
[1] https://www.tipranks.com/stocks/algn/forecast